Comments

Portage Biotech Stock Price, Quotes and Forecasts

Q: What sector and industry does Portage Biotech (PRTG) operate in?

Portage Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

PRTGNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$4.20

0.061.45%

Pre-Market: Feb 28, 8:30 AM EDT

Portage Biotech (PRTG) Forecast

News Earnings Portage Biotech (PRTG) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Portage Biotech Stock Price, Quotes and Forecasts | NASDAQ:PRTG | Benzinga

Explore Portage Biotech stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PRTG.

Open	-
Close	-
Volume / Avg.	91.00 / 703.09K
Day Range	- - -
52 Wk Range	2.10 - 23.01
Market Cap	$6.91M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	38
Short Interest	1%
Days to Cover	1

Recent News

Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

What's Going On With Portage Biotech Shares Tuesday?

Portage Biotech stock is trading higher after the company announced it signed a letter of intent with Immunova for the potential sale of its subsidiary.

Dylan Berman

Crude Oil Down Over 1%; US Industrial Production Declines In November

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.6

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	91.00 / 703.09K
Day Range	- - -
52 Wk Range	2.10 - 23.01
Market Cap	$6.91M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	38
Short Interest	1%
Days to Cover	1

About Portage Biotech Inc

Sector

Health Care

Industry

Biotechnology

Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products thr...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Portage Biotech (PRTG) stock?

You can purchase shares of Portage Biotech (NASDAQ:PRTG) through any online brokerage.

View our list of the best stock brokerages

Who are Portage Biotech (PRTG) competitors?

Other companies in Portage Biotech’s space includes: Galecto (NASDAQ:GLTO), Dermata Therapeutics (NASDAQ:DRMA), Can Fite Biofarma (AMEX:CANF), Indaptus Therapeutics (NASDAQ:INDP) and Ensysce Biosciences (NASDAQ:ENSC).

What is the forecast, or price target, for Portage Biotech (PRTG) stock?

Portage Biotech has a consensus price target of $14.50.

What is the current price for Portage Biotech (PRTG)?

The stock price for Portage Biotech (NASDAQ: PRTG) is $4.2001 last updated February 28, 2025 at 8:30 AM EST.

Does Portage Biotech (PRTG) pay a dividend?

There are no upcoming dividends for Portage Biotech.

When is Portage Biotech (NASDAQ:PRTG) reporting earnings?

Portage Biotech’s Q3 earnings are confirmed for Tuesday, March 18, 2025.

Is Portage Biotech (PRTG) going to split?

There is no upcoming split for Portage Biotech.

What sector and industry does Portage Biotech (PRTG) operate in?

Portage Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.